Anti-asthma therapy
US6224907A · kind A · utility
20Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 1999 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | Feb 12, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A dosage form is disclosed for administering a leukatriene-receptor antagonist to a patient over time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.